{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:11:34Z","timestamp":1786371094240,"version":"build-2736575974"},"reference-count":54,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Bialystok","award":["B.SUB.25.318"],"award-info":[{"award-number":["B.SUB.25.318"]}]},{"name":"Medical University of Bialystok","award":["B.SUB.26.321"],"award-info":[{"award-number":["B.SUB.26.321"]}]},{"award":["B.SUB.25.318"],"award-info":[{"award-number":["B.SUB.25.318"]}],"id":[{"id":"https:\/\/ror.org\/00y4ya841","id-type":"ROR","asserted-by":"publisher"}]},{"award":["B.SUB.26.321"],"award-info":[{"award-number":["B.SUB.26.321"]}],"id":[{"id":"https:\/\/ror.org\/00y4ya841","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Bladder cancer (BC) is one of the most commonly diagnosed cancers of the genitourinary system and ranks ninth in terms of incidence worldwide. Due to the varied clinical course of the disease and the frequent tendency for tumor recurrence, diagnostic studies are being conducted to find non-invasive and prognostic markers that could be helpful in diagnosing BC. The aim of this review was to present the current state of knowledge on the role of extracellular matrix metalloproteinases (MMPs) and pro-inflammatory cytokines in the pathogenesis of bladder cancer, as well as to assess their potential as biomarkers measured in body fluids. The study reviewed the literature published in English between 2012 and 2025. The studies included clinical and experimental research analysing the expression and activity of selected metalloproteinases, including MMP-2, MMP-9, MMP-7 and MMP-1, and pro-inflammatory cytokines such as interleukins (ILs): IL-6, IL-8, IL-17, and IFN-\u03b3 in serum, urine, and tumor tissues of patients with BC, using immunochemical methods and genetic analyses. The collected data indicate that MMPs play a key role in the degradation of the extracellular matrix, facilitating invasion, angiogenesis, and metastasis. Elevated concentrations of MMP-2 and MMP-9, especially in urine, correlate with the clinical stage and histopathological malignancy of the tumor. MMP-7 may be important in the early stages of carcinogenesis, while MMP-1 shows promising potential in multi-marker panels. At the same time, chronic inflammation and increased pro-inflammatory cytokine activity play a key role in modulating the tumor microenvironment. IL-6 and IL-8 have high diagnostic value in urine tests, with IL-6 also serving as a prognostic marker. IL-17 is associated with more aggressive forms of the disease, while IFN-\u03b3 may reflect the immune response to BC treatment. There is also evidence of positive feedback between cytokines and MMPs, which intensifies the process of tumor invasion and progression. Therefore, both extracellular matrix metalloproteinases and pro-inflammatory cytokines may be promising non-invasive biomarkers of bladder cancer. Their combined assessment can increase the diagnostic and prognostic value compared to the analysis of individual parameters. However, further multicentre prospective studies are needed for clinical validation and standardisation of the methods of determination.<\/jats:p>","DOI":"10.3390\/ijms27073218","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T07:57:55Z","timestamp":1775116675000},"page":"3218","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Matrix Metalloproteinases and Pro-Inflammatory Cytokines in Bladder Cancer: Diagnostic and Prognostic Perspectives: Narrative Review"],"prefix":"10.3390","volume":"27","author":[{"given":"Urszula","family":"Lipka","sequence":"first","affiliation":[{"name":"Department of Biochemical Diagnostics, Medical University of Bialystok, Waszyngtona 15A St., 15-269 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5992-8098","authenticated-orcid":false,"given":"Karolina","family":"Orywal","sequence":"additional","affiliation":[{"name":"Department of Biochemical Diagnostics, Medical University of Bialystok, Waszyngtona 15A St., 15-269 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4854-7155","authenticated-orcid":false,"given":"Monika","family":"Gudowska-Sawczuk","sequence":"additional","affiliation":[{"name":"Department of Biochemical Diagnostics, Medical University of Bialystok, Waszyngtona 15A St., 15-269 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"ref_1","first-page":"27330","article-title":"A Review of the Etiology and Epidemiology of Bladder Cancer: All You Need to Know","volume":"14","author":"Halaseh","year":"2022","journal-title":"Cureus"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","article-title":"Epidemiology of Bladder Cancer: A Systematic Review and Contemporary Update of Risk Factors in 2018","volume":"74","author":"Cumberbatch","year":"2018","journal-title":"Eur. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors","volume":"84","author":"Jubber","year":"2023","journal-title":"Eur. Urol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21037\/tau.2018.09.11","article-title":"Epidemiology, aetiology and screening of bladder cancer","volume":"8","author":"Cumberbatch","year":"2019","journal-title":"Transl. Androl. Urol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Dobruch, J., and Oszczud\u0142owski, M. (2021). Bladder Cancer: Current Challenges and Future Directions. Medicina, 57.","DOI":"10.3390\/medicina57080749"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s15006-015-7539-4","article-title":"Harnblasenkrebs: Fr\u00fche Detektion essenziell f\u00fcr die erfolgreiche Therapie","volume":"157","author":"Jokisch","year":"2015","journal-title":"MMW Fortschritte Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Hansel","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Monar, G.V.F., Reynolds, T., Gordon, M., Moon, D., and Moon, C. (2023). Molecular Markers for Bladder Cancer Screening: An Insight into Bladder Cancer and FDA-Approved Biomarkers. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241814374"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"12880","DOI":"10.1038\/s41598-025-95002-0","article-title":"Accurate bladder cancer diagnosis using ensemble deep learning","volume":"15","author":"Saraya","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00345-018-2503-4","article-title":"Molecular markers in bladder cancer","volume":"37","author":"Soria","year":"2019","journal-title":"World J. Urol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.2174\/1389557515666150909141404","article-title":"The Use of Biomarkers for Bladder Cancer Diagnosis and Surveillance","volume":"16","author":"Grubmuller","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Alouini, S. (2024). Risk Factors Associated with Urothelial Bladder Cancer. Int. J. Environ. Res. Public Health, 21.","DOI":"10.3390\/ijerph21070954"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrc3817","article-title":"Molecular biology of bladder cancer: New insights into pathogenesis and clinical diversity","volume":"15","author":"Knowles","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","article-title":"Bladder cancer","volume":"3","author":"Sanli","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_15","first-page":"547","article-title":"The role of matrix metalloproteinases in pathogenesis of human bladder cancer","volume":"68","author":"Bryda","year":"2021","journal-title":"Acta Biochim. Pol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canlet.2013.01.042","article-title":"Microenvironment and tumor cell plasticity: An easy way out","volume":"341","author":"Taddei","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1070383","DOI":"10.3389\/fmolb.2022.1070383","article-title":"Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?","volume":"9","author":"Chianese","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Michalczyk, K., and Cymbaluk-P\u0142owska, A. (2021). Metalloproteinases in Endometrial Cancer- Are They Worth Measuring?. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222212472"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Li, R.L., Duan, H.X., Liang, Q., Huang, Y.L., Wang, L.Y., Zhang, Q., Wu, C.J., Liu, S.Q., and Peng, W. (2022). Targeting matrix metalloproteinases: A promising strategy for herbal medicines to treat rheumatoid arthritis. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1046810"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.18632\/aging.204021","article-title":"Molecular characterization of matrix metalloproteinase gene family across primates","volume":"14","author":"Pan","year":"2022","journal-title":"Aging"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Guszcz, T., Lukaszewski, Z., Gorodkiewicz, E., and Hermanowicz, A. (2025). Potential of Proteases in the Diagnosis of Bladder Cancer. Mol. Divers. Preserv. Int., 17.","DOI":"10.3390\/cancers17213460"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Almutairi, S., Kalloush, H.M., Manoon, N.A., and Bardaweel, S. (2023). Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013\u20132023). Mol. Divers. Preserv. Int., 28.","DOI":"10.3390\/molecules28145567"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/0973-1482.163761","article-title":"Elevated expression of matrix metalloproteinase-9 is associated with bladder cancer pathogenesis","volume":"14","author":"Wu","year":"2018","journal-title":"J. Cancer Res. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13062-025-00599-x","article-title":"Matrix Metalloproteinase-9 is associated with tumor microvironment remodeling of bladder cancer","volume":"20","author":"Fang","year":"2025","journal-title":"Biol. Direct"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7565834","DOI":"10.1155\/2018\/7565834","article-title":"A Matrix Metalloproteinase-1 Polymorphism, MMP1-1607 (1G>2G), Is Associated with Increased Cancer Risk: A Meta-Analysis Including 21,327 Patients","volume":"2018","author":"Zhou","year":"2018","journal-title":"Dis. Markers"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"584","DOI":"10.5173\/ceju.2024.0214","article-title":"Expression and activity of matrilysins\u2014Matrix metalloproteinases 7 and 26 in human urinary bladder cancer","volume":"77","author":"Mlynarczyk","year":"2024","journal-title":"Cent. Eur. J. Urol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40169-014-0031-4","article-title":"Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer","volume":"3","author":"Thezenas","year":"2014","journal-title":"Clin. Transl. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"19224","DOI":"10.1097\/MD.0000000000019224","article-title":"Dominative role of MMP-14 over MMP-15 in human urinary bladder carcinoma on the basis of its enhanced specific activity","volume":"99","author":"Kudelski","year":"2020","journal-title":"Medicine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"22275","DOI":"10.1002\/jbt.22275","article-title":"MMP-2 and MMP-9 as prognostic markers for the early detection of urinary bladder cancer","volume":"33","author":"Fouad","year":"2018","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.3892\/ol.2015.3558","article-title":"Evaluation of MMP-2, MMP-9, TIMP-1, TIMP-2, NGAL and MMP-9\/NGAL complex in urine and sera from patients with bladder cancer","volume":"10","author":"Ricci","year":"2015","journal-title":"Oncol. Lett."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.56434\/j.arch.esp.urol.20257809.162","article-title":"Diagnostic Values of Serum Matrix Metalloproteinase-9 and Nuclear Matrix Protein 22 for Bladder Cancer","volume":"78","author":"Chen","year":"2025","journal-title":"Arch. Esp. Urol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Vanarsa, K., Castillo, J., Wang, L., Lee, K.H., Pedroza, C., Lotan, Y., and Mohan, C. (2023). Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging. BMC Med., 21.","DOI":"10.1186\/s12916-023-02813-x"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Oyler, H.J., Bruton, L.G., Maher, A.J., Yu, D.A., Shely, N.W., Wakefield, M.R., and Fang, Y. (2025). Cytokine Therapy in Bladder Cancer: Mechanisms, Efficacy, and Future Prospects. Curr. Issues Mol. Biol., 47.","DOI":"10.3390\/cimb47040278"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Rea, I.M., Gibson, D.S., McGilligan, V., McNerlan, S.E., Alexander, H.D., and Ross, O.A. (2018). Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00586"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_36","unstructured":"McManus, L.M., and Mitchell, R.N. (2014). Systematic inflammation. Pathobiology of Human Disease, Elsevier."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Gr\u0119bowski, R., Saluk, J., Bijak, M., Szmeraj, J., and Wigner, P. (2023). Variability, Expression, and Methylation of IL-6 and IL-8 Genes in Bladder Cancer Pathophysiology. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076266"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/cncy.22767","article-title":"Urinary IL-6 and IL-8 as predictive markers in bladder urothelial carcinoma: A pilot study","volume":"132","author":"VandenBussche","year":"2024","journal-title":"Cancer Cytopathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"647","DOI":"10.24976\/Discov.Med.202537195.56","article-title":"Interleukins in Urological Diseases","volume":"37","author":"Akdere","year":"2025","journal-title":"Discov. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"102378","DOI":"10.1016\/j.clgc.2025.102378","article-title":"Prognostic Role of Serum IL-6 Levels in Bladder Cancer Patients and Hints of its Origin","volume":"23","author":"Engelmann","year":"2025","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.21037\/tcr.2019.03.16","article-title":"Interleukin 6 signaling maintains the stem-like properties of bladder cancer stem cells","volume":"8","author":"Wei","year":"2019","journal-title":"Transl. Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.14740\/wjon1536","article-title":"Association Between Interleukin-6 Levels and Lymph Node Metastasis in Bladder Cancer Patients","volume":"13","author":"Warli","year":"2022","journal-title":"World J. Oncol."},{"key":"ref_43","first-page":"1059","article-title":"A Prognostic Impact of Interleukin 17 (IL-17) as an Immune-Marker in Patients with Bladder Cancer","volume":"77","author":"Mousa","year":"2022","journal-title":"Razi Vaccine Serum Res. Inst."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41419-025-07821-8","article-title":"FGFR inhibitors promote the autophagic degradation of IFN-y-induced PD-L1 and alleviate the PD-l1-mediated transcriptional suppression of FGFR3-TACC3 in non-muscle-invasive bladder cancer","volume":"16","author":"Lin","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"115445","DOI":"10.1016\/j.celrep.2025.115445","article-title":"AGO2 mediates immunotherapy failure via suppressing tumor IFN-gamma response-dependent CD8+ T cell immunity","volume":"44","author":"Wang","year":"2025","journal-title":"Cell Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1010428317697552","DOI":"10.1177\/1010428317697552","article-title":"Predictive role of serum and urinary cytokines in invasion and recurrence of bladder cancer","volume":"39","author":"Kumari","year":"2017","journal-title":"Tumor Biol."},{"key":"ref_47","first-page":"111","article-title":"Value of Immunological Biomarkers in Early Prediction of Bacillus Calmette-Guerin Failure in High-Risk Non-muscle-invasive Bladder Cancer","volume":"6","author":"Awadalla","year":"2023","journal-title":"Ann. Urol. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Wigner, P., Gr\u0119bowski, R., Bijak, M., Saluk-Bijak, J., and Szmeraj, J. (2021). The Interplay between Oxidative Stress, Inflammation and Angiogenesis in Bladder Cancer Development. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094483"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Catalano, M., Roviello, G., Santi, R., Villari, D., Spatafora, P., Galli, I.C., Sessa, F., Conte, F.L., Mini, E., and Cai, T. (2023). Inflammation in Urological Malignancies: The Silent Killer. Multidiscip. Digit. Publ. Inst., 24.","DOI":"10.3390\/ijms24010866"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Urquidi, V., Chang, M., Dai, Y., Kim, J., Wolfson, E.D., Goodison, S., and Rosser, C.J. (2012). IL-8 as urinary biomarker for the detection of bladder cancer. BMC Urol., 12.","DOI":"10.1186\/1471-2490-12-12"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Reis, S.T., Leite, K.R.M., Piovesan, L.F., Pontes-Junior, J., Viana, N.I., Abe, D.K., Crippa, A., Moura, C.M., Adonias, S.P., and Srougi, M. (2012). Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer. BMC Urol., 12.","DOI":"10.1186\/1471-2490-12-18"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Lee, S.J., Lee, E.J., Kim, S.K., Jeong, P., Cho, Y.H., Yun, S.J., Kim, S., Kim, G.Y., Choi, Y.H., and Cha, E.J. (2012). Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0040267"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s40291-013-0023-x","article-title":"Bladder cancer detection and monitoring: Assessment of urine- and blood-based marker tests","volume":"17","author":"Goodison","year":"2013","journal-title":"Mol. Diagn. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.eururo.2025.02.010","article-title":"A Systematic Review of Novel Interavesical Approaches for the Treatment of Patients with Non-muscle-invasive Bladder Cancer","volume":"88","author":"Ghodoussipour","year":"2025","journal-title":"Eur. Urol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/7\/3218\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:15:07Z","timestamp":1775276107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/7\/3218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":54,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["ijms27073218"],"URL":"https:\/\/doi.org\/10.3390\/ijms27073218","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]}}}